Website design for biotech company

Development Research UI design UX design Web design +2
 
Client
Myosin Therapeutics
Timeline
2 months

Myosin Therapeutics is a privately held biopharmaceutical company developing medications that target cellular motor proteins, specialized molecular machines that convert energy into mechanical work inside cells.

2023
 
 

Colors & typography

We aligned the color palette and typography to create a balanced and engaging visual experience that emphasizes both style and readability.

 

Logo redesign

We designed a new logo that preserves the company’s original logo concept and symbol while introducing a new typeface for the name.

 

Monochrome logo variations

The updated logo is available in two versions: one in black and white, and the other with inverted colors. It can also be integrated with the brand’s color palette when needed.

 
Monochrome version
Monochrome in inversion
 
What we did:

Created a website that highlights the organization’s innovative research in cancer therapy and substance use disorders

 

Evaluating usability

The old website lacked essential information, while some pages were overloaded with excessive content, making the structure difficult to navigate.

 
 

Sitemap

Following the usability assessment, we developed an updated website structure that enhances user navigation while also improving the site’s search engine visibility.

Navigation
Projects
News
 

UI/UX redesign outcomes

 
 

UI components

We designed a set of UI components, including buttons, tabs, input fields etc. These were combined into a UI kit to ensure consistency and flexibility, making future design updates easy to implement.

 
UI
Components
 

First website interaction

The redesign features a clean layout and simple navigation, making it easy for users to find key information about the development of targeted therapies for central nervous system and oncology indications.

 
UI
Main page
 
Website showing news about Myosin Therapeutics receiving $2.8M funding from NIH/NIDA for advancing MT-110 to treat methamphetamine use disorder. Website showing news about Myosin Therapeutics receiving $2.8M funding from NIH/NIDA for advancing MT-110 to treat methamphetamine use disorder.
UI
News
UI
Technology page
 
UI
Pipeline page
 

Functional blocks and a clear content hierarchy

 
UI
About page
 
UI
Contact modal
UI
Slider
 

Post-redesign traffic analysis

 
 

Stylized 3D graphics

A key feature of the new design is the 3D visuals that highlight the lab’s key research areas.

 
 

Responsive layout

In order to maintain a consistent user experience, we designed specific layouts for desktops, tablets, and smartphones, ensuring responsiveness across all devices.

 
Team page
About page
 
Main page
Team bio modal
 

Have a project in mind?
Let’s get in touch

Share your project idea with us! If our partnership isn't the right fit, we're happy to provide valuable insights that could still benefit you.

Get in touch

View our projects

See how we transform businesses with our research-driven and innovative design approach.